S
Summit Sawhney
Researcher at University of Alberta
Publications - 4
Citations - 3001
Summit Sawhney is an academic researcher from University of Alberta. The author has contributed to research in topics: Human Metabolome Database & Internal medicine. The author has an hindex of 3, co-authored 3 publications receiving 2613 citations.
Papers
More filters
Journal ArticleDOI
HMDB: The human metabolome database
David S. Wishart,Dan Tzur,Craig Knox,Roman Eisner,An Chi Guo,Nelson Young,Dean Cheng,Kevin Jewell,David Arndt,Summit Sawhney,Chris Fung,Lisa Nikolai,Michael J. Lewis,Marie-Aude Coutouly,Ian D. Forsythe,Peter Tang,Savita Shrivastava,Kevin Jeroncic,Paul Stothard,Godwin Amegbey,David Block,David Hau,James Wagner,Jessica Miniaci,Melisa Clements,Mulu Gebremedhin,Natalie Guo,Ying Wen Zhang,Gavin E. Duggan,Glen D. MacInnis,Alim M. Weljie,Reza Dowlatabadi,Fiona Bamforth,Derrick L. J. Clive,Russell Greiner,Liang Li,Thomas J. Marrie,Brian D. Sykes,Hans J. Vogel,Lori M.M. Querengesser +39 more
TL;DR: The Human Metabolome Database is designed to address the broad needs of biochemists, clinical chemists, physicians, medical geneticists, nutritionists and members of the metabolomics community.
Journal ArticleDOI
The human cerebrospinal fluid metabolome.
David S. Wishart,David S. Wishart,Michael J. Lewis,Joshua A. Morrissey,M.D. Flegel,Kevin Jeroncic,Yeping Xiong,Dean Cheng,Roman Eisner,Bijaya Gautam,Dan Tzur,Summit Sawhney,Fiona Bamforth,Russell Greiner,Liang Li +14 more
TL;DR: This work has chosen to characterize CSF as the first biofluid to be intensively scrutinized and identified and quantify essentially all of the metabolites that can be commonly detected in the human CSF metabolome.
Journal ArticleDOI
Transarterial chemoembolization in patients with hepatocellular carcinoma: Predictors of survival
Summit Sawhney,Aldo J. Montano-Loza,Peter Salat,Mairin McCarthy,Norman M. Kneteman,Judith Meza-Junco,Richard J. Owen +6 more
TL;DR: Reduction in tumour size after the first TACE procedure was associated with better survival, primarily if patients had more than a 3% reduction in tumours assessed by three-dimensional measurement.
Journal ArticleDOI
Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary – an intriguing dilemma: report of three cases and review of the literature
M. Mansoor,Morgan Young-Speirs,Bing Ren,Geoffrey Gotto,Larissa Merten,Summit Sawhney,Farshid Siadat,Andres M. Acosta,Abbas Agaimy,Kiril Trpkov +9 more
TL;DR: This poster aims to raise awareness of the existence of extrarenal renal cell carcinoma (RCC) and the need for further research into itsigenicity and prognosis.